• Markets
  • icon
  • Companies
SNT · ASX

Syntara Limited (ASX:SNT)

AU$0.029

 0.0 (0.0%)
ASX:Live
14/06/2024 03:45:56 PM
Near Resistance HALO Price Momentum HALO Ords HALO Consensus Value GROWTH AUS +4
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

SNT Overview

SNT Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Strong

Growth

Earnings

Neutral

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About SNT

Telephone

Address

Description

Syntara Ltd. is a pharmaceutical research company, which engages in the development and commercialization of healthcare products for fibrotic and inflammatory diseases. Its respiratory products include bronchitol and aridol. The company was founded by Brett Charlton and William B. Cowden on May 29, 1998 and is headquartered in Sydney, Australia.

SNT Price Chart

Key Stats

Market Cap

AU$28.66M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.01 - 0.06

Trade Value (12mth)

AU$8,631.00

1 week

16%

1 month

61.11%

YTD

52.63%

1 year

-38.3%

All time high

4.3122100830078125

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

-121.40%

Operating Cashflow

-$7m

Free Cash Flow Return

-64.30%

ROIC

-100.40%

Interest Coverage

-70.50

Quick Ratio

2.10

Other Data

Shares on Issue (Fully Dilluted)

727m

HALO Sector

Next Company Report Date

14-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

SNT Announcements

Latest Announcements

Date Announcements

12 June 24

SNT to present in MST Access Hidden Gems Webinar

×

SNT to present in MST Access Hidden Gems Webinar

24 May 24

Change of registry address notification

×

Change of registry address notification

17 May 24

Investor Webinar Presentation

×

Investor Webinar Presentation

30 April 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

30 April 24

Quarterly Activities Report

×

Quarterly Activities Report

30 April 24

Presentation for quarterly shareholder briefing

×

Presentation for quarterly shareholder briefing

30 April 24

Updated company investor presentation

×

Updated company investor presentation

30 April 24

Application for quotation of securities - SNT

×

Application for quotation of securities - SNT

29 April 24

Notification of cessation of securities - SNT

×

Notification of cessation of securities - SNT

24 April 24

SNT Quarterly Report and Investor Briefing

×

SNT Quarterly Report and Investor Briefing

15 April 24

Change in substantial holding

×

Change in substantial holding

10 April 24

Phase 2 Trial Reaches 50% Recruitment

×

Phase 2 Trial Reaches 50% Recruitment

19 March 24

Investor presentation - NWR Virtual Healthcare Conference

×

Investor presentation - NWR Virtual Healthcare Conference

14 March 24

SNT to present at NWR Virtual Healthcare Conference

×

SNT to present at NWR Virtual Healthcare Conference

06 March 24

Investor Presentation

×

Investor Presentation

04 March 24

Change in substantial holding

×

Change in substantial holding

29 February 24

Application for quotation of securities - SNT

×

Application for quotation of securities - SNT

29 February 24

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

14 February 24

SNT to Trial New Cancer Indication Following MRFF Grant

×

SNT to Trial New Cancer Indication Following MRFF Grant

14 February 24

Notification regarding unquoted securities - SNT

×

Notification regarding unquoted securities - SNT

14 February 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

14 February 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

09 February 24

Change in substantial holding

×

Change in substantial holding

08 February 24

Application for quotation of securities - SNT

×

Application for quotation of securities - SNT

07 February 24

Change in substantial holding

×

Change in substantial holding

SNT Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock N/A N/A -0.02 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock N/A N/A -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     PE X Lock Lock Lock Lock 12.7 N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 3.0 N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock N/A N/A -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock N/A N/A -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A -23.1 Lock Lock Lock
DPS $ Lock Lock Lock Lock N/A N/A 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.0 N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock N/A N/A 0.01 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock N/A N/A 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock N/A N/A 656 Lock Lock Lock
Basic m Lock Lock Lock Lock N/A N/A 656 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock N/A N/A 13 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock N/A N/A 15 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock N/A N/A -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A -22.6 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock N/A N/A 123 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock N/A N/A -16 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A -121.4 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock N/A N/A 2 Lock Lock Lock
EBIT $m Lock Lock Lock Lock N/A N/A -18 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A -135.6 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock N/A N/A -17 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock N/A N/A -5 Lock Lock Lock
Net Income $m Lock Lock Lock Lock N/A N/A -11 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A -87.7 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock N/A N/A -7 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock N/A N/A 7 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock N/A N/A -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A -0.6 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock N/A N/A 9 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock N/A N/A 24 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock N/A N/A -7 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock N/A N/A 14 Lock Lock Lock
Equity $m Lock Lock Lock Lock N/A N/A 10 Lock Lock Lock
Invested Capital Lock Lock Lock Lock N/A N/A 10 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock N/A N/A -47.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock N/A N/A -118.8 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock N/A N/A -131.7 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock N/A N/A -100.4 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock N/A N/A -64.3 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A -70.5 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock N/A N/A 0.5 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock N/A N/A -75.2 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock N/A N/A 2.3 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock N/A N/A 2.1 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock N/A N/A 49.4 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock N/A N/A -90.6 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock N/A N/A 1.7 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 8.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock N/A N/A 1.2 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock N/A N/A 12.2 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock N/A N/A 0.5 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock N/A N/A 0.5 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock N/A N/A -128.2 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock N/A N/A -69.1 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock N/A N/A -47.3 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock N/A N/A 2.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock N/A N/A -118.8 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock N/A N/A 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock N/A N/A -118.8 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 45.7 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock N/A N/A 212.9 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock N/A N/A 258.6 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock N/A N/A 26.4 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock N/A N/A 232.2 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

SNT Shortsell

Frequently Asked Questions

The current share price of Syntara Limited (SNT:ASX) is AU$0.029.
The 52-week high share price for Syntara Limited (SNT:ASX) is AU$0.06.
The 52-week low share price for Syntara Limited (SNT:ASX)? is AU$0.01.
Syntara Limited (SNT:ASX) does not pay a dividend.
Syntara Limited (SNT:ASX) does not pay a dividend.
Syntara Limited (SNT:ASX) has a franking level of 0.0%.
Syntara Limited (SNT:ASX) is classified in the Healthcare.
The current P/E ratio for Syntara Limited (SNT:ASX) is .